ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN 印刷: 0893-9675
ISSN オンライン: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2017020855
pages 99-107

Yin Yang I as an Epimodulator of miRNAs in the Metastatic Cascade

Carlo Ruosi
Department of Human Health Federico II University of Naples, Naples, Italy
Gianluca Colella
Department of Human Health Federico II University of Naples, Naples, Italy
Flavio Fazioli
Division of Musculoskeletal Oncology Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy
Roberta Miceli
S.C. Cellular Biology and Biotherapy, National Cancer Institute, Pascale Foundation, Naples, Italy
Michele Gallo
Division of Musculoskeletal Oncology Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy
Mariano Giuseppe Di Salvatore
Division of Musculoskeletal Oncology Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy
Amelia Cimmino
Institute of Genetics and Biophysics–CNR, Naples, Italy
Filomena de Nigris
Department of Biochemistry Biophysics and General Pathology University of Campania Luigi Vanvitelli, Naples, Italy; Sbarro Institute for Cancer Research and Molecular Medicine, Centre for Biotechnology College of Science and Technology, Temple University, Philadelphia, Pennsylvania

要約

Yin Yang 1 (YY1) belongs to the polycomb group (PcG) of proteins that modify chromatin epigenetically during dynamic regulation of their target genes. The predominant feature of YY1 is the zinc finger, an ancient structural motif that mediates protein–protein interactions and is capable of interacting with both DNA and RNA. Evidence reveals that YY1 acts predominantly as an epigenetic modulator, influencing the activity and/or localization of epigenetic modifiers molecules such as DNA methylation transferases, histone deacetylases, or non-coding RNAs. Deregulation of the epigenome is observed frequently in a variety of cancer types and is often correlated directly with advanced metastatic stages and poor prognosis. In this review, we address the current understanding of YY1 as a recruiter of epi-modifier molecules in the mechanism of aberrant regulation of target genes as a part of the metastatic cascade.


Articles with similar content:

Genetic and Epigenetic Control of RKIP Transcription
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 6
Milad S. Bitar, Kevin Qin, Kam C. Yeung, Fahd Al-Mulla, Hanna Tegegne, Ila Datar, Robert J. Trumbly
Evolution of Transcriptional Control from Prokaryotic Beginnings to Eukaryotic Complexities
Critical Reviews™ in Eukaryotic Gene Expression, Vol.9, 1999, issue 3-4
Lili Huang, Arthur B. Pardee, Rong J. Guan
Architectural Genetic and Epigenetic Control of Regulatory Networks: Compartmentalizing Machinery for Transcription and chromatin remodeling in nuclear Microenvironments
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 2
Sayyed Kaleem Zaidi, Janet L. Stein, Jane B. Lian, Martin Montecino, Jeffrey A. Nickerson, Andre J. van Wijnen, Gary Stein, Anthony N. Imbalzano
Posttranslational Regulation of p53 Tumor Suppressor Protein Function
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 1
Steve A. Maxwell, Jack A. Roth
Pathogenesis of Psoriatic Arthritis
Critical Reviews™ in Immunology, Vol.39, 2019, issue 5
Maria Sole Chimenti, Francesco Caso, Luca Navarini, Luisa Costa, Leonardo Punzi